FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385166006: Conventional release vaginal gel (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479429018 Vaginal gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537293019 Conventional release vaginal gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3537294013 Conventional release vaginal gel (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
9551000188110 gel vaginal fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vaginal gel Is a Vaginal dose form (dose form) true Inferred relationship Some
Vaginal gel Is a A semi-solid dose form consisting of a hydrophilic gel. false Inferred relationship Some
Vaginal gel Has dose form administration method (attribute) A method of administration of a dose form by placing or spreading on a body surface. true Inferred relationship Some
Vaginal gel Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the vagina. true Inferred relationship Some
Vaginal gel Has dose form release characteristic (attribute) A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties. true Inferred relationship Some
Vaginal gel Has basic dose form (attribute) A semi-solid dose form consisting of a hydrophilic gel. true Inferred relationship Some
Vaginal gel Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Povidone-iodine 10% vaginal gel Has manufactured dose form False Vaginal gel Inferred relationship Some
Metronidazole 7.5 mg/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Acetic acid 9.2 mg/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Dinoprostone 400 microgram/mL vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) Has manufactured dose form True Vaginal gel Inferred relationship Some
Progesterone 40 mg/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Progesterone 80 mg/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Product containing precisely nonoxinol 20 milligram/1 milliliter conventional release vaginal gel (clinical drug) Has manufactured dose form True Vaginal gel Inferred relationship Some
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some
Iodine (as povidone iodine) 100 mg/g vaginal gel Has manufactured dose form True Vaginal gel Inferred relationship Some

This concept is not in any reference sets

Back to Start